Acute	acute	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
elevations	elevations	O	O	O	O
with	with	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
men	men	O	O	O	O
with	with	O	O	O	O
borderline	borderline	O	O	O	O
systemic	systemic	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Whether	whether	O	O	O	O
the	the	O	O	O	O
vasoconstrictive	vasoconstrictive	O	O	O	O
actions	actions	O	O	O	O
of	of	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
are	are	O	O	O	O
enhanced	enhanced	O	O	O	O
in	in	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
persons	persons	O	O	O	O
has	has	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
demonstrated	demonstrated	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
3.3	3.3	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
versus	versus	O	O	O	O
placebo	placebo	O	O	O	O
was	was	O	O	O	O
tested	tested	O	O	O	O
in	in	O	O	O	O
48	48	O	O	O	O
healthy	healthy	O	O	O	O
men	men	O	O	O	O
(	(	O	O	O	O
aged	aged	O	O	O	O
20	20	O	O	O	O
to	to	O	O	O	O
35	35	O	O	O	O
years	years	O	O	O	O
)	)	O	O	O	O
selected	selected	O	O	O	O
after	after	O	O	O	O
screening	screening	O	O	O	O
on	on	O	O	O	O
2	2	O	O	O	O
separate	separate	O	O	O	O
occasions	occasions	O	O	O	O
.	.	O	O	O	O

Borderline	borderline	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
men	men	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
24	24	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
selected	selected	O	O	O	O
with	with	O	O	O	O
screening	screening	O	O	O	O
systolic	systolic	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
BP	bp	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
140	140	O	O	O	O
to	to	O	O	O	O
160	160	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
and/or	and/or	O	O	O	O
diastolic	diastolic	O	O	O	O
BP	bp	O	O	O	O
90	90	O	O	O	O
to	to	O	O	O	O
99	99	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
.	.	O	O	O	O

Low-risk	low-risk	O	O	O	O
controls	controls	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
24	24	O	O	O	O
)	)	O	O	O	O
reported	reported	O	O	O	O
no	no	O	O	O	O
parental	parental	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
had	had	O	O	O	O
screening	screening	O	O	O	O
BP	bp	O	O	O	O
<	<	O	O	O	O
130/85	130/85	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
.	.	O	O	O	O

Participants	participants	O	O	O	O
were	were	O	O	O	O
then	then	O	O	O	O
tested	tested	O	O	O	O
on	on	O	O	O	O
2	2	O	O	O	O
occasions	occasions	O	O	O	O
after	after	O	O	O	O
12-hour	12-hour	O	O	O	O
abstinence	abstinence	O	O	O	O
from	from	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
each	each	O	O	O	O
of	of	O	O	O	O
2	2	O	O	O	O
protocols	protocols	O	O	O	O
;	;	O	O	O	O
this	this	O	O	O	O
required	required	O	O	O	O
a	a	O	O	O	O
total	total	O	O	O	O
of	of	O	O	O	O
4	4	O	O	O	O
laboratory	laboratory	O	O	O	O
visits	visits	O	O	O	O
.	.	O	O	O	O

Caffeine-induced	caffeine-induced	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
diastolic	diastolic	O	O	O	O
BP	bp	O	O	O	O
were	were	O	O	O	O
2	2	O	O	O	O
to	to	O	O	O	O
3	3	O	O	O	O
times	times	O	O	O	O
larger	larger	O	O	O	O
in	in	O	O	O	O
borderline	borderline	O	O	O	O
subjects	subjects	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
controls	controls	O	O	O	O
(	(	O	O	O	O
+	+	O	O	O	O
8.4	8.4	O	O	O	O
vs	vs	O	O	O	O
+	+	O	O	O	O
3.8	3.8	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
,	,	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.0001	0.0001	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
were	were	O	O	O	O
attributable	attributable	O	O	O	O
to	to	O	O	O	O
larger	larger	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
impedance-derived	impedance-derived	O	O	O	O
measures	measures	O	O	O	O
of	of	O	O	O	O
systemic	systemic	O	O	O	O
vascular	vascular	O	O	O	O
resistance	resistance	O	O	O	O
(	(	O	O	O	O
+	+	O	O	O	O
135	135	O	O	O	O
vs	vs	O	O	O	O
+	+	O	O	O	O
45	45	O	O	O	O
dynes.s.cm-5	dynes.s.cm-5	O	O	O	O
,	,	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.004	0.004	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
findings	findings	O	O	O	O
were	were	O	O	O	O
consistent	consistent	O	O	O	O
and	and	O	O	O	O
reached	reached	O	O	O	O
significance	significance	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
protocols	protocols	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
percentage	percentage	O	O	O	O
of	of	O	O	O	O
borderline	borderline	O	O	O	O
subjects	subjects	O	O	O	O
in	in	O	O	O	O
whom	whom	O	O	O	O
diastolic	diastolic	O	O	O	O
BP	bp	O	O	O	O
changes	changes	O	O	O	O
exceeded	exceeded	O	O	O	O
the	the	O	O	O	O
median	median	O	O	O	O
control	control	O	O	O	O
response	response	O	O	O	O
was	was	O	O	O	O
96	96	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

Consequently	consequently	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
all	all	O	O	O	O
participants	participants	O	O	O	O
exhibited	exhibited	O	O	O	O
normotensive	normotensive	O	O	O	O
levels	levels	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
resting	resting	O	O	O	O
predrug	predrug	O	O	O	O
baseline	baseline	O	O	O	O
,	,	O	O	O	O
33	33	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
borderline	borderline	O	O	O	O
subjects	subjects	O	O	O	O
achieved	achieved	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
BP	bp	O	O	O	O
levels	levels	O	O	O	O
after	after	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
ingestion	ingestion	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
borderline	borderline	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
men	men	O	O	O	O
,	,	O	O	O	O
exaggerated	exaggerated	O	O	O	O
responses	responses	O	O	O	O
to	to	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
:	:	O	O	O	O
selective	selective	O	O	O	O
for	for	O	O	O	O
diastolic	diastolic	O	O	O	O
BP	bp	O	O	O	O
,	,	O	O	O	O
consistent	consistent	O	O	O	O
with	with	O	O	O	O
greater	greater	O	O	O	O
vasoconstriction	vasoconstriction	O	O	O	O
,	,	O	O	O	O
replicated	replicated	O	O	O	O
in	in	O	O	O	O
2	2	O	O	O	O
protocols	protocols	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
representative	representative	O	O	O	O
of	of	O	O	O	O
nearly	nearly	O	O	O	O
all	all	O	O	O	O
borderline	borderline	O	O	O	O
hypertensives	hypertensives	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
suspect	suspect	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
potential	potential	O	O	O	O
for	for	O	O	O	O
caffeine	caffeine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
stabilize	stabilize	O	O	O	O
high	high	O	O	O	O
resistance	resistance	O	O	O	O
states	states	O	O	O	O
in	in	O	O	O	O
susceptible	susceptible	O	O	O	O
persons	persons	O	O	O	O
suggests	suggests	O	O	O	O
that	that	O	O	O	O
its	its	O	O	O	O
use	use	O	O	O	O
may	may	O	O	O	O
facilitate	facilitate	O	O	O	O
their	their	O	O	O	O
disease	disease	O	DISEASE	OTHERS	I
progression	progression	O	DISEASE	OTHERS	I
,	,	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
hinder	hinder	O	O	O	O
accurate	accurate	O	O	O	O
diagnosis	diagnosis	O	O	O	O
and	and	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

